These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7534665)

  • 1. The nature of the epithelium in acquired cholesteatoma: Part 3--Cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture.
    Lee RJ; Sidey C; Narula AA; James RF
    Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):516-20. PubMed ID: 7534665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
    Kuczkowski J; Kobierska-Gulida G; Izycka-Swieszewska E; Potocka M; Mikaszewski B; Sierszeń W
    Otolaryngol Pol; 2010; 64(4):219-24. PubMed ID: 20873097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Air-exposed tissue culture of human middle ear epithelium and meatal epidermis: a method to study the advancing front of cholesteatoma.
    Albers-op t' Hof BM; Peek FA; Huisman MA; Grote JJ
    Acta Otolaryngol; 2002 Oct; 122(7):720-5. PubMed ID: 12484648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine aural cholesteatoma: a histological and immunohistochemical study.
    Banco B; Grieco V; Di Giancamillo M; Greci V; Travetti O; Martino P; Mortellaro CM; Giudice C
    Vet J; 2014 Jun; 200(3):440-5. PubMed ID: 24775276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nature of the epithelium in acquired cholesteatoma. Part 2. Cell culture.
    Lee RJ; Mackenzie IC; Robinson BK; Gantz BJ
    Clin Otolaryngol Allied Sci; 1991 Oct; 16(5):493-7. PubMed ID: 1742900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokeratin patterns of tissues related to cholesteatoma pathogenesis.
    Van Blitterswijk CA; Grote JJ; Lutgert RW; Hesseling SC; Out CJ; Van Muijen GN; Fransen JA
    Ann Otol Rhinol Laryngol; 1989 Aug; 98(8 Pt 1):635-40. PubMed ID: 2475048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues.
    Broekaert D; Coucke P; Leperque S; Ramaekers F; Van Muijen G; Boedts D; Leigh I; Lane B
    Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):931-8. PubMed ID: 1280020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study of cell proliferation using BrdU labelling on tympanic membrane, external auditory canal and induced cholesteatoma in Mongolian gerbils.
    Park K; Chun YM; Park HJ; Lee YD
    Acta Otolaryngol; 1999; 119(8):874-9. PubMed ID: 10728926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma.
    Yetiser S; Satar B; Aydin N
    Otol Neurotol; 2002 Sep; 23(5):647-52. PubMed ID: 12218613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
    Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
    Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.
    Shinoda H; Huang CC
    Eur Arch Otorhinolaryngol; 1995; 252(7):385-90. PubMed ID: 8562031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
    Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
    Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased permeability of the epithelium of middle ear cholesteatoma.
    Koizumi H; Suzuki H; Ohbuchi T; Kitamura T; Hashida K; Nakamura M
    Clin Otolaryngol; 2015 Apr; 40(2):106-14. PubMed ID: 25319490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle inhibitory protein p27 in human middle ear cholesteatoma.
    Kuczkowski J; Bakowska A; Pawelczyk T; Narozny W; Mikaszewski B
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(5):296-301. PubMed ID: 16825801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of tenascin in cholesteatoma and external auditory meatal skin compared to retroauricular epidermis.
    Schilling V; Lang S; Rasp G; Mack B; Nerlich A
    Acta Otolaryngol; 1996 Sep; 116(5):741-6. PubMed ID: 8908253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of PTHrP and RANKL in acquired middle ear cholesteatoma epithelium.
    Xie S; Pan Z; Yin T; Ren J; Liu W
    Acta Otolaryngol; 2020 May; 140(5):351-355. PubMed ID: 32108533
    [No Abstract]   [Full Text] [Related]  

  • 17. Cathepsin L activity and its inhibitor in human otitis media.
    Kusunoki T; Nishida S; Murata K; Kobashi K; Nakatani H; Hiwasa T; Tomura T
    J Otolaryngol; 2001 Jun; 30(3):157-61. PubMed ID: 11771045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin expression in cholesteatoma matrix, meatal epidermis and middle ear epithelium. A preliminary report.
    van Blitterswijk CA; Grote JJ
    Acta Otolaryngol; 1988; 105(5-6):529-32. PubMed ID: 2456666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasiveness of fibroblasts from experimental cholesteatomas.
    Chole RA; Faddis BT; Chamberlain S; Magilke D
    Otol Neurotol; 2001 Jan; 22(1):15-7. PubMed ID: 11314709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The roles of interleukin-1 alpha, tumor necrosis factor-alpha and parathyroid hormone-related protein in bone resorption of cholesteatoma otitis].
    Kinoshita K
    Nihon Jibiinkoka Gakkai Kaiho; 1994 Aug; 97(8):1472-80. PubMed ID: 7931803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.